Skip to product information
1 of 1

Phospho-LRRK2 (S1292) Recombinant Rabbit mAb (S-2521-13)

Phospho-LRRK2 (S1292) Recombinant Rabbit mAb (S-2521-13)

Catalog Number: S0B6710 Application: WB Reactivity: Human Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen LRRK2
Synonyms Leucine-rich repeat serine/threonine-protein kinase 2; Dardarin; PARK8
Immunogen Synthetic Peptide
Location Cytoplasm, Cytoskeleton, Lysosome, Endosome, Mitochondrion, Endoplasmic reticulum
Accession Q5S007
Clone Number S-2521-13
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:500-1:1000 Hu

Background

Phospho-LRRK2 (S1292) refers to the specific form of the Parkinson's disease-associated protein LRRK2 that is phosphorylated at its serine 1292 residue. LRRK2 is a multifunctional kinase, and mutations in it are among the most common genetic causes of familial Parkinson's disease. The S1292 site is located within the WD40 domain of LRRK2, and its phosphorylation status is dynamically regulated by upstream kinases (such as PKA) and phosphatases (such as PP1). Phosphorylation at this site can influence LRRK2's kinase activity, GTPase activity, interactions with other proteins (e.g., 14-3-3 proteins), subcellular localization (such as binding to microtubules and membrane structures), and neurotoxicity. Research indicates that S1292 phosphorylation levels may be altered in LRRK2 mutants (e.g., G2019S) and are associated with the pathological mechanisms of Parkinson's disease (such as neuronal dysfunction and vesicle trafficking abnormalities). Therefore, it is considered a potential therapeutic target and biomarker. Detection of phosphorylation at this site is typically performed using specific antibodies for Western Blot or immunohistochemical analysis.

Picture

Western Blot

WB result of Phospho-LRRK2 (S1292) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-LRRK2 (S1292) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: LRRK2 WT transfected 293F whole cell lysate 20 µg
Lane 2: LRRK2 mutant G2019S transfected 293F whole cell lysate 20 µg
Lane 3: LRRK2 mutant S1292A transfected 293F whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 286 kDa
Observed MW: 286 kDa
This blot was developed with high sensitivity substrate